Department of Oncology, Nanchang University, Nanchang, Jiangxi, China (mainland).
Department of Oncology, Jiujiang First People's Hospital, Jiujiang, Jiangxi, China (mainland).
Med Sci Monit. 2021 Mar 11;27:e931623. doi: 10.12659/MSM.931623.
Approval for publication of this manuscript was not obtained by all the authors, which is in breach of this journal's editorial guidelines. Reference: Yongqing Han, Dayou Shi, Jingao Li: Inhibition of Nasopharyngeal Carcinoma by Beta-Lapachone Occurs by Targeting the Mammalian Target of Rapamycin (mTOR)/PI3K/AKT Pathway, Reactive Oxygen Species (ROS) Production, and Autophagy Induction. Med Sci Monit 2019; 25:8995-9002. 10.12659/MSM.915463.
该手稿的发表并未获得所有作者的批准,这违反了本刊的编辑准则。参考文献:韩永清、时大勇、李敬高:β-拉帕醌通过靶向哺乳动物雷帕霉素靶蛋白(mTOR)/PI3K/AKT 通路、活性氧(ROS)产生和自噬诱导抑制鼻咽癌。医学科学监测 2019;25:8995-9002. 10.12659/MSM.915463.